Behind blue eyes – Evidence for ocular nutritional supplements on the Scandinavian market


  • Tomas Bro Department of Ophthalmology Eksjö, Region Jönköping County and Department of Biomedical and Clinical Sciences, Linköping University, Linköping
  • Jan Ygge Department of Clinical Neuroscience, Marianne Bernadotte Centrum, Karolinska Institute St. Erik Eye hospital, Solna, Sweden



Kosttilskudd rettet mot øyehelse, Ocular nutritional supplements, AMD, AREDS


Nutritional supplements for eye health are very popular, but the size of the market makes it difficult to grasp for the clinician. To guide patients and clinicians in the subject it would therefore be valuable to have a list of available products and their content. The purpose of this study was to investigate the ocular nutritional supplements available on the Scandinavian market and how their doses relate to current evidence. A list of nutritional supplements for ocular health available on the Scandinavian market was compiled by structured internet searches, and the products and their contents were compared with current evidence and legislated upper tolerable levels. Out of 104 products on the Scandinavian market, only two products reached the Age-Related Eye Disease Study 2 (AREDS2)-formula at the recommended dose. One additional product reached the same formula if the recommended dose was exceeded. As only two nutritional supplements for ocular health on the Scandinavian market reached the AREDS2-dose at recommended dose, clinicians offering such substances need to have knowledge not only about the substances but also of the doses. In the future it would be welcome if the health claims for nutritional supplements were based on placebo-controlled intervention studies, to avoid ineffective products.


AREDS Research Group. (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology, 119(10), 1417–36.

AREDS2 Research Group. (2013). Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA, 309(19), 2005–15.

Bartlett, H., & Eperjesi, F. (2005). Possible contraindications and adverse reactions associated with the use of ocular nutritional supplements. Ophthalmic & Physiological Optics, 25(3), 179–94.

Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2012). Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database of Systematic Reviews, (3), CD007176.

Bussel, I., & Aref, A. A. (2014). Dietary factors and the risk of glaucoma: A review. Theraputic Advances in Chronic Disease, 5(4), 188–94.

Canter, P. H., & Ernst, E. (2004). Anthocyanosides of vaccinium myrtillus (bilberry) for night vision–a systematic review of placebo-controlled trials. Survey of Ophthalmology, 49(1), 38–50.

Dansk Oftalmologisk Selskab. (2015). AMD og kosttilskud.

DTU Fødevareinstituttet. (2016). De fleste får nok vitaminer og mineraler fra kosten alene. /media/Institutter/Foedevareinstituttet/Publikationer/Pub-2016/E-artikel-De-fleste-faar-nok-vitaminer-og-mineraler-fra kosten alene.ashx?la=da

European Food Safety Authority. (2006). Tolerable upper intake levels for vitamin and minerals.

European Food Safety Authority. (2009a). EFSA Journal, 7(9), Article 1221.

European Food Safety Authority. (2009b). EFSA Journal, 7(9), Article 1229.

European Food Safety Authority. (2010). EFSA Journal, 8(10), Article 1814.

Evans, J. R., & Lawrenson, J. G. (2017a). Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database of Systematic Reviews, 7, CD000253.

Evans, J. R., & Lawrenson, J. G. (2017b). Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database of Systematic Reviews, 7, CD000254. .1002/14651858.CD000254.pub4

Fødevarestyrelsen. (2017). Søg i kosttilskud.

Fødevarestyrelsen. (2018). For meget zink i kosttilskud. https:/ / /Nyheder / Aktuelt / Sider / Tilbagekaldte %20f%C3%B8devarer%202018/For_meget_zink_i_kosttilskud.aspx

Helse- og omsorgsdepartementet. (2004). FOR-2004-05-20-755.

Helse- og omsorgsdepartementet. (2017). FOR-2017-05-30-671.

Hui, F., Tang, J., Williams, P. A., McGuinness, M. B., Hadoux, X., Casson, R. J., Coote, M., Trounce, I. A., Martin, K. R., van Wijngaarden, P., & Crowston, J. G. (2020). Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial. Clinical and Experimental Ophthalmology.

Klein, E. A., Thompson, J., I. M., Tangen, C. M., Crowley, J. J., Lucia, M. S., Goodman, P. J., Minasian, L. M., Ford, L. G., Parnes, H. L., Gaziano, J. M., Karp, D. D., Lieber, M. M., Walther, P. J., Klotz, L., Parsons, J. K., Chin, J. L., Darke, A. K., Lippman, S. M., Goodman, G. E., … Baker, L. H. (2011). Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA, 306(14), 1549–56.

Lawrenson, J. G., & Evans, J. R. (2015). Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration. Cochrane Database of Systematic Reviews, (4), CD010015. https : / / doi . org / 10 . 1002 / 14651858.CD010015.pub3

Livsmedelsverket. (2020a). Riskvärdering av vitaminer och mineraler i kosttillskott.

bilaga 1 (Report).

Livsmedelsverket. (2020b). Vem behöver extra vitaminer och mineraler och- innehall/kosttillskott/vem- behoverextra-vitaminer

Mathew, M. C., Ervin, A. M., Tao, J., & Davis, R. M. (2012). Antioxidant vitamin supplementation

for preventing and slowing the progression of age-related cataract.

Cochrane Database of Systematic Reviews, (6), CD004567.

Miljø- og Fødevareministeriet. (1996). Bekendtgørelse om kosttilskud, BEK nr 860 af 25/09/1996.

Miljø- og Fødevareministeriet. (2015). BEK nr 1465 af 07/12/2015.

Miljø- og Fødevareministeriet. (2017a). BEK nr 1239 af 27/11/2017.

Miljø- og Fødevareministeriet. (2017b). Vejledning om kosttilskud VEJ nr. 10213 af 13/12/2017.

Miller, 3., E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005). Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Annals of Internal Medicine, 142(1), 37–46.

Molina-Leyva, I., Molina-Leyva, A., & Bueno-Cavanillas, A. (2017). Efficacy of nutritional

supplementation with omega-3 and omega-6 fatty acids in dry eye syndrome: A systematic review of randomized clinical trials. Acta Ophthalmologica, 95(8), 677–685.

NAFKAM. (2017). Rapport: Bruk av alternativ behandling i Norge 2016. http://www.

Svensk Egenvård. (2016). Egenvårdsmarknaden 2015. content/uploads/2016/03/statistik-2015.pdf

The European Commission. (2012). Commission regulation no 432/2012. https:

// Ulbricht, C., Basch, E., Basch, S., Bent, S., Boon, H., Burke, D., Costa, D., Falkson,

C., Giese, N., Goble, M., Hashmi, S., Mukarjee, S., Papaliodis, G., Seamon, E., Tanguay-Colucci, S., Weissner, W., & Woods, J. (2009). An evidence-based systematic review of bilberry (vaccinium myrtillus) by the natural standard research collaboration. Journal of Dietary Supplements, 6(2), 162–200. 1080/19390210902861858

Yong, J. J., Scott, I. U., & Greenberg, P. B. (2015). Ocular nutritional supplements: Are their ingredients and manufacturers’ claims evidence-based? Ophthalmology, 122(3), 595–9.

Zhang, Y., Coogan, P., Palmer, J. R., Strom, B. L., & Rosenberg, L. (2009). Vitamin and mineral use and risk of prostate cancer: The case-control surveillance study. Cancer Causes




How to Cite

Bro, T., & Ygge, J. (2021). Behind blue eyes – Evidence for ocular nutritional supplements on the Scandinavian market . Scandinavian Journal of Optometry and Visual Science, 14(1), 1–7.



Scientific Article